As new products introduced this year have shown, HPLC systems continue to evolve. Speed, resolution and ease of use remain key criteria for end-users so as to increase productivity. Vendors continually optimize and develop HPLC techniques, such as UHPLC and LCxLC, to meet these demands. Agilent Technologies, Shimadzu and Thermo Fisher Scientific each launched new […]
With more than $200 million in sales last year, Austrian firm Anton Paar has a long history of manufacturing analytical instruments for several product markets. This breadth is not common among companies of its size, and its instruments range from materials characterization to molecular spectroscopy to process analytics systems. The company’s high proportion of R&D […]
Fiscal fourth quarter sales ending September 30 for Brooks Automation’s Life Science Systems (LSS) segment climbed 77.4% to $20.0 million to account for 16% of company sales. Excluding the acquisition of Matrical (see IBO 7/31/13), sales grew 63% driven by demand for automated sample-management systems and services. Including the acquisition, Product and Service revenue grew […]
Encouraging economic data and corporate-earnings reports lifted US equity markets to new highs in November. Following 4.6% growth in the second quarter, US third quarter GDP growth was revised upwards 40 basis points to 3.9% due to strong consumer spending. However, weaker-than-expected capital-goods orders and a spike in US jobless claims, coupled with slow manufacturing […]
The calendar-year third quarter produced mixed financial results for the revenues of major publicly held analytical instrument and laboratory-product businesses. Growth in selected clinical and pharmaceutical end-markets offset continued weakness in industrial end-markets and China. Companies forecast little change for the next quarter. Revenues for the seven businesses whose results are detailed on pages 9–11 […]
This month, Eurostat released the first estimates of 2013 R&D expenditures of the 28 EU member states. Also provided was a breakdown of expenditures by sector, and R&D intensity (R&D expenditure as a percentage of GDP) for each country. The report of R&D intensity is the first using the new European System of Accounts (ESA). […]
To augment IBO’s coverage of quarterly financial results, IBO will now provide sidebar summaries of results for companies not in the Sales Indexes. Third quarter FEI sales grew 4.2%, 3.5% organically, to $218.5 million (see page 12), with acquisitions contributing 0.9% and currency lowering sales 0.2%. Industry sales grew 3.3%, 1.7% organically, to account for […]
Hach’s SL1000 Portable Parallel Analyzer (PPA) is a handheld device for water-quality testing. It was developed with the capabilities that customers most commonly wanted in instruments for field testing—testing more parameters in less time, eliminating error and performing tests more easily. The PPA has inputs for two probes and slots—each with a pump—for four Chemkeys, […]
The purchase prices of certain acquisitions are not announced initially but are later announced in SEC filings. Below are acquisitions whose price was subsequently disclosed.
Thirteen of the 16 companies in the IBO Laboratory Sales Index reported quarterly earnings before this issue’s publication. Including estimates for companies yet to report, third quarter revenue for the Index grew more than 5% excluding currency, to $6,304 million. Excluding Illumina, Index sales advanced approximately 3% organically. Operating profit improved more than 10% to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
